Praveen Kumar Panangattukara Prabhakaran

Dr. Praveen Kumar Panangattukara Prabhakaran

Biomedical Engineering, Michigan State University, East Lansing, Michigan, USA
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2012 in RSC Advances
Verified
Journal Article
Closed access
PDF file
VHV. Haridas
V. Haridas
SSSrikanta Sahu
Srikanta Sahu
PPPraveen Kumar Panangattukara Prabhakaran
Praveen Kumar Panangattukara Prabhakaran
ASAppa Rao Sapala
Appa Rao Sapala
Anion receptors have attracted growing interest because of their role in chemistry, the environment, biology and medicine. The mis-regulation of anion flux causes a variety of lethal human diseases. Recently, triazole has been found to be an excellent motif for molecular recognition. This review depicts an overall picture of developments in the design and synthesis of anion receptors along with an up-to-date emphasis on the triazole unit as a motif for anion recognition. The acidic CH of triazole is involved in binding with the anions, which makes these receptors different from other classes of receptors. The chemo- and regio-selectivity of the click reaction provides further impetus for future developments in this area.

28 December 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
PPPraveen Kumar Panangattukara Prabhakaran
Praveen Kumar Panangattukara Prabhakaran
Dong-Kwon LimDong-Kwon Lim
Dong-Kwon Lim
Gold nanoparticles (AuNPs) have been extensively investigated for their use in various biomedical applications. Owing to their biocompatibility, simple surface modifications, and electrical and unique optical properties, AuNPs are considered promising nanomaterials for use in in vitro disease diagnosis, in vivo imaging, drug delivery, and tissue engineering applications. The functionality of AuNPs may be further expanded by producing hybrid nanocomposites with polymers that provide additional functions, responsiveness, and improved biocompatibility. Polymers may deliver large quantities of drugs or genes in therapeutic applications. A polymer alters the surface charges of AuNPs to improve or modulate cellular uptake efficiency and their biodistribution in the body. Furthermore, designing the functionality of nanocomposites to respond to an endo- or exogenous stimulus, such as pH, enzymes, or light, may facilitate the development of novel therapeutic applications. In this review, we focus on the recent progress in the use of AuNPs and Au-polymer nanocomposites in therapeutic applications such as drug or gene delivery, photothermal therapy, and tissue engineering.

10 April 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
MHMeghan L. Hill
Meghan L. Hill
SCSeock-Jin Chung
Seock-Jin Chung
HWHyun-Joo Woo
Hyun-Joo Woo
CPCho Rong Park
Cho Rong Park
KHKay Hadrick
Kay Hadrick
Taeho KimTaeho Kim
Taeho Kim
Glioblastoma is one of the most aggressive and invasive types of brain cancer with a 5-year survival rate of 6.8%. With limited options, patients often have poor quality of life and are moved to palliative care after diagnosis. As a result, there is an extreme need for a novel theranostic method that allows for early diagnosis and noninvasive treatment as current peptide-based delivery standards may have off-target effects. Prussian Blue nanoparticles (PBNPs) have recently been investigated as photoacoustic imaging (PAI) and photothermal ablation agents. However, due to their inability to cross the blood–brain barrier (BBB), their use in glioblastoma treatment is limited. By utilizing a hybrid, biomimetic nanoparticle composed of a PBNP interior and a U-87 cancer cell-derived exosome coating (Exo:PB), we show tumor-specific targeting within the brain and selective thermal therapy potential due to the strong photoconversion abilities. Particle characterization was carried out and showed a complete coating around the PBNPs that contains exosome markers. In vitro cellular uptake patterns are similar to native U-87 exosomes and when exposed to an 808 nm laser, show localized cell death within the specified region. After intravenous injection of Exo:PB into subcutaneously implanted glioblastoma mice, they have shown effective targeting and eradication of tumor volume compared to PEG-coated PBNPs (PEG:PB). Through systemic administration of Exo:PB particles into orthotopic glioblastoma-bearing mice, the PBNP signal was detected in the brain tumor region through PAI. It was seen that Exo:PB had preferential tumor accumulation with less off-targeting compared to the RGD:PB control. Ex vivo analysis validated specific targeting with a direct overlay of Exo:PB with the tumor by both H&E staining and Ki67 labeling. Overall, we have developed a novel biomimetic material that can naturally cross the BBB and act as a theranostic agent for systemic targeting of glioblastoma tissue and photothermal therapeutic effect.

1 January 2024 in Nanotheranostics
Verified
Journal Article
Open access
PDF file
PPPraveen Kumar Panangattukara Prabhakaran
Praveen Kumar Panangattukara Prabhakaran
RMRitu Mahajan
Ritu Mahajan
Gold nanoparticles (AuNPs) possess unique optical properties, making them highly attractive nanomaterials for biomedical research. By exploiting the diverse optical characteristics of various gold nanostructures, significant enhancements can be achieved in biosensing and biomedical imaging fields. The potential of AuNPs can be enhanced by creating hybrid nanocomposites with polymers, which offer supplementary functionalities, responsiveness, and enhanced biocompatibility. Moreover, polymers can modify the surface charges of AuNPs, thereby improving or controlling the efficiency of cellular uptake and the distribution of these nanoparticles within the body. Polymer modification using AuNPs offers a wide array of benefits, including improved sensitivity, specificity, speed, contrast, resolution, and penetration depth. By incorporating AuNPs into the polymer matrix, these enhancements synergistically enhance the overall performance of various applications. This versatile approach opens promising possibilities in fields such as biomedicine, nanotechnology, and sensor development, providing a powerful platform for advanced research and technological innovations. In this review, the recent advancements in polymer-AuNPs synthesis and their applications in bioimaging will be covered. Prospects and challenges associated with polymer-AuNPs-based bioimaging agents in preclinical and clinical investigations will be discussed.

9 July 2025 in Nanotheranostics
Verified
Journal Article
Open access
PDF file
PPPraveen Kumar Panangattukara Prabhakaran
Praveen Kumar Panangattukara Prabhakaran
SSShivanjali Saxena
Shivanjali Saxena
RJRakesh Joshi
Rakesh Joshi
Surface-enhanced Raman scattering (SERS) has emerged as a powerful technique for bioanalysis, offering ultrasensitive molecular detection and identification capabilities. The signal intensity and reproducibility of Raman responses from analytes are primarily influenced by the surface roughness and nanogap architecture of plasmonic materials. Numerous designs, plasmonic nanostructures, and fabrication methods have been explored to optimize these factors. The precise nanogap ranging from 0.5 to 1.0 nm between the metallic nanoparticles and analytes offers significantly higher Raman enhancement, enabling single-molecule detection through SERS. With advancements in nano- and microfabrication techniques, the development of highly efficient SERS substrates has significantly enhanced the analytical performance in various biomedical applications. This review comprehensively examines the latest innovations in nano- and microfabricated SERS sensors, emphasizing their design, fabrication techniques, and functionalization strategies for biomolecular detection, bioimaging, and theranostic applications. Furthermore, we explore the growing role of artificial intelligence (AI) in optimizing SERS-based bioanalysis, from enhancing spectral data processing to developing machine learning models for pattern recognition and diagnostic applications. The integration of AI with SERS technologies holds great promise for revolutionizing point-of-care diagnostics, real-time biomarker monitoring, and personalized medicine.

2 April 2025 in Colorants
Verified
Journal Article
Open access
PDF file
PPPraveen Kumar Panangattukara Prabhakaran
Praveen Kumar Panangattukara Prabhakaran
SSShivanjali Saxena
Shivanjali Saxena
RJRakesh Joshi
Rakesh Joshi
BODIPY (Boron-Dipyrromethene) dyes have emerged as versatile fluorescent probes in cellular imaging and therapeutic applications owing to their unique chemical properties, including high fluorescence quantum yield, strong extinction coefficients, and remarkable photostability. This review synthesizes the recent advancements in BODIPY dyes, focusing on their deployment in biological imaging and therapy. The exceptional ability of BODIPY dyes to selectively stain cellular structures enables precise visualization of lipids, proteins, and nucleic acids within live and tumor cells, thereby facilitating enhanced understanding of biochemical processes. Moreover, BODIPY derivatives are increasingly utilized in Photodynamic therapy (PDT) and Photothermal therapies (PTT) for targeting cancer cells, where their capability to generate cytotoxic reactive oxygen species upon light activation offers a promising approach to tumor treatment. Recently, BODIPY derivatives have been used for Boron Neutron Capture Therapy (BNCT) for various tumors, and it is a growing research field. Advancements in nanotechnology have allowed the fabrication of BODIPY dye-based nanomedicines, either alone or with the use of metallic nanoparticles as a matrix offering the development of a new class of bioimaging and theragnostic agents. This review also discusses innovative BODIPY-based formulations and strategies that amplify therapeutic efficacy while minimizing adverse effects, underscoring the potential of these dyes as integral components in next-generation diagnostic and therapeutic modalities. By summarizing current research and future perspectives, this review highlights the critical importance of BODIPY dyes in advancing the fields of cellular imaging and treatment methodologies.